Skip to main content
VulnerabilityPublished Updated

CVE-2025-58091: MedDream PACS Premium · Cross-site Scripting

Affects MedDream PACS PremiumSource CVE Database V5

0

Not known to be exploited · CVSS 6.1 Medium.

Data as of 26 Oct 2026, 14:05 UTC

CVSS 3.1 base score
6.1Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 20% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 Jan 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
MedDreamMedDream PACS PremiumAffected
  • =7.3.6.870
Fixed in–

AI-suggested

Organizations should immediately implement strict input validation and output encoding on the 'thumbnaildir' parameter and any other user-controllable inputs in the PACS web interface to prevent script injection. Web application firewalls (WAFs) can be configured to detect and block suspicious URL patterns targeting this parameter. Administrators should monitor web server logs for unusual requests containing script payloads. User awareness training should emphasize caution when clicking on unsolicited or suspicious links, especially in email or messaging contexts. Since no official patches are currently available, organizations should engage with MedDream support to obtain updates or workarounds. Network segmentation and limiting access to the PACS web interface to trusted internal networks or VPN users can reduce exposure. Regular security assessments and penetration testing focused on web application vulnerabilities will help identify residual risks. Finally, ensure that all software components are updated promptly once vendor patches are released.

Description

CVE-2025-58091 is a reflected cross-site scripting (XSS) vulnerability in MedDream PACS Premium version 7.3.6.870, specifically affecting the 'thumbnaildir' parameter in the config.php functionality. An attacker can craft malicious URLs that, when visited by a user, execute arbitrary JavaScript code in the victim's browser. This vulnerability requires user interaction (clicking the malicious link) but no authentication, and it can lead to partial compromise of confidentiality and integrity through session hijacking or data manipulation. The vulnerability has a CVSS score of 6.1 (medium severity) and no known exploits in the wild as of now. European healthcare organizations using this PACS software are at risk, especially those with public-facing web interfaces.

References

Community reviews

Loading reviews…